Denise W.
- Country
- Germany
- Department
- Universitätsklinikum Magdeburg A.ö.R. Zentrum für Innere Medizin, Klinik für Hämatologie u Onkologie
Research Overview
- Phase IV Rollover Study Evaluating Long-Term Safety of Ruxolitinib Alone or in Combination with Panobinostat, Siremadlin, or Rineterkib in Eligible Patients
- Evaluation of Ruxolitinib Versus Best Available Therapy in High-Risk Polycythemia Vera and Essential Thrombocythemia Patients
- Evaluation of Axicabtagene Ciloleucel CAR T-Cell Therapy in Relapsed or Refractory Primary Mediastinal B-Cell Lymphoma Patients
Data & Insights
Has run more than one trial at 8 of 43 partner sites.
Specializations
Hematologic Disorders
The investigator specializes in treating myeloproliferative neoplasms, with particular focus on polycythemia vera and essential thrombocythemia.
- Blood Disorder Management
- High-risk Patient Care
- Therapeutic Assessment
This clinical expert evaluates novel therapeutic approaches for blood disorders affecting platelet and red blood cell production.
Treatment Innovation
The investigator evaluates therapeutic interventions for patients with high-risk hematologic conditions, focusing on comparative treatment strategies.
- Treatment Optimization
- Clinical Efficacy Studies
- Safety Assessment
Their work encompasses the evaluation of targeted therapies against established treatment protocols in hematologic disorders.
Patient Care Focus
The investigator concentrates on developing treatment strategies for patients with advanced blood disorders requiring specialized therapeutic intervention.
- Risk Assessment
- Treatment Selection
- Patient Monitoring
Their expertise extends to managing complex cases requiring individualized treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.